_id
69105ac3ccc777a4e85d57bb
Ticker
DGX
Name
Quest Diagnostics Incorporated
Exchange
NYSE
Address
500 Plaza Drive, Secaucus, NJ, United States, 07094
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.questdiagnostics.com
Description
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Last Close
181.57
Volume
379694
Current Price
181.59
Change
0.0110150355234952
Last Updated
2025-11-29T12:13:55.429Z
Image
-
Ipo Date
1996-12-17T00:00:00.000Z
Market Cap
21154756608
Next Dividend Date
2026-01-28T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.8
Dividend Yield
1.762211575527287
Sentiment
0.9383521739130435
Sentiment Sources
23
Rating
3.8947
Target Price
197.3125
Strong Buy
8
Buy
1
Hold
10
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
2816000000
Cost Of Revenue
1867000000
Gross Profit
949000000
Operating Expenses
563000000
Operating Income
386000000
Interest Expense
69000000
Pretax Income
336000000
Net Income
245000000
Eps
2.168141592920354
Dividends Per Share
89000000
Shares Outstanding
111242362
Income Tax Expense
77000000
EBITDA
547000000
Operating Margin
13.707386363636365
Total Other Income Expense Net
-50000000
Cash
432000000
Short Term Investments
-
Receivables
1456000000
Inventories
186000000
Total Current Assets
2407000000
Property Plant Equipment
2794000000
Total Assets
16197000000
Payables
1457000000
Short Term Debt
677000000
Long Term Debt
5171000000
Total Liabilities
8821000000
Equity
7258000000
Depreciation
142000000
Change In Working Capital
35000000
Cash From Operations
563000000
Capital Expenditures
144000000
Cash From Investing
-201000000
Cash From Financing
-247000000
Net Change In Cash
113000000
PE
22.2042
PB
2.8271796638192344
ROE
3.37558556076054
ROA
1.5126257949002901
FCF
419000000
Fcf Percent
0.14879261363636365
Piotroski FScore
4
Health Score
58
Deep Value Investing Score
4
Defensive Investing Score
8
Dividend Investing Score
4
Economic Moat Investing Score
6.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
6
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
2816000000
Quarters > 0 > income Statement > cost Of Revenue
1867000000
Quarters > 0 > income Statement > gross Profit
949000000
Quarters > 0 > income Statement > operating Expenses
563000000
Quarters > 0 > income Statement > operating Income
386000000
Quarters > 0 > income Statement > interest Expense
69000000
Quarters > 0 > income Statement > pretax Income
336000000
Quarters > 0 > income Statement > net Income
245000000
Quarters > 0 > income Statement > eps
2.168141592920354
Quarters > 0 > income Statement > dividends Per Share
89000000
Quarters > 0 > income Statement > shares Outstanding
113000000
Quarters > 0 > income Statement > income Tax Expense
77000000
Quarters > 0 > income Statement > EBITDA
547000000
Quarters > 0 > income Statement > operating Margin
13.707386363636365
Quarters > 0 > income Statement > total Other Income Expense Net
-50000000
Quarters > 0 > balance Sheet > cash
432000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1456000000
Quarters > 0 > balance Sheet > inventories
186000000
Quarters > 0 > balance Sheet > total Current Assets
2407000000
Quarters > 0 > balance Sheet > property Plant Equipment
2794000000
Quarters > 0 > balance Sheet > total Assets
16197000000
Quarters > 0 > balance Sheet > payables
1457000000
Quarters > 0 > balance Sheet > short Term Debt
677000000
Quarters > 0 > balance Sheet > long Term Debt
5171000000
Quarters > 0 > balance Sheet > total Liabilities
8821000000
Quarters > 0 > balance Sheet > equity
7258000000
Quarters > 0 > cash Flow > net Income
259000000
Quarters > 0 > cash Flow > depreciation
142000000
Quarters > 0 > cash Flow > change In Working Capital
35000000
Quarters > 0 > cash Flow > cash From Operations
563000000
Quarters > 0 > cash Flow > capital Expenditures
144000000
Quarters > 0 > cash Flow > cash From Investing
-201000000
Quarters > 0 > cash Flow > cash From Financing
-247000000
Quarters > 0 > cash Flow > net Change In Cash
113000000
Quarters > 0 > ratios > PE
2.168141592920354
Quarters > 0 > ratios > PB
2.8271796638192344
Quarters > 0 > ratios > ROE
3.37558556076054
Quarters > 0 > ratios > ROA
1.5126257949002901
Quarters > 0 > ratios > FCF
419000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.14879261363636365
Quarters > 0 > health Score
58
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
2761000000
Quarters > 1 > income Statement > cost Of Revenue
1818000000
Quarters > 1 > income Statement > gross Profit
943000000
Quarters > 1 > income Statement > operating Expenses
505000000
Quarters > 1 > income Statement > operating Income
438000000
Quarters > 1 > income Statement > interest Expense
69000000
Quarters > 1 > income Statement > pretax Income
393000000
Quarters > 1 > income Statement > net Income
282000000
Quarters > 1 > income Statement > eps
2.495575221238938
Quarters > 1 > income Statement > dividends Per Share
90000000
Quarters > 1 > income Statement > shares Outstanding
113000000
Quarters > 1 > income Statement > income Tax Expense
97000000
Quarters > 1 > income Statement > EBITDA
596000000
Quarters > 1 > income Statement > operating Margin
15.863817457442956
Quarters > 1 > income Statement > total Other Income Expense Net
-45000000
Quarters > 1 > balance Sheet > cash
319000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1419000000
Quarters > 1 > balance Sheet > inventories
187000000
Quarters > 1 > balance Sheet > total Current Assets
2198000000
Quarters > 1 > balance Sheet > property Plant Equipment
2775000000
Quarters > 1 > balance Sheet > total Assets
15969000000
Quarters > 1 > balance Sheet > payables
1309000000
Quarters > 1 > balance Sheet > short Term Debt
675000000
Quarters > 1 > balance Sheet > long Term Debt
5169000000
Quarters > 1 > balance Sheet > total Liabilities
8623000000
Quarters > 1 > balance Sheet > equity
7228000000
Quarters > 1 > cash Flow > net Income
296000000
Quarters > 1 > cash Flow > depreciation
143000000
Quarters > 1 > cash Flow > change In Working Capital
55000000
Quarters > 1 > cash Flow > cash From Operations
544000000
Quarters > 1 > cash Flow > capital Expenditures
108000000
Quarters > 1 > cash Flow > cash From Investing
-124000000
Quarters > 1 > cash Flow > cash From Financing
-293000000
Quarters > 1 > cash Flow > net Change In Cash
131000000
Quarters > 1 > ratios > PE
2.495575221238938
Quarters > 1 > ratios > PB
2.838913945766464
Quarters > 1 > ratios > ROE
3.901494189263974
Quarters > 1 > ratios > ROA
1.7659214728536539
Quarters > 1 > ratios > FCF
436000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.1579137993480623
Quarters > 1 > health Score
60
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2652000000
Quarters > 2 > income Statement > cost Of Revenue
1789000000
Quarters > 2 > income Statement > gross Profit
863000000
Quarters > 2 > income Statement > operating Expenses
517000000
Quarters > 2 > income Statement > operating Income
346000000
Quarters > 2 > income Statement > interest Expense
72000000
Quarters > 2 > income Statement > pretax Income
294000000
Quarters > 2 > income Statement > net Income
220000000
Quarters > 2 > income Statement > eps
1.9469026548672566
Quarters > 2 > income Statement > dividends Per Share
84000000
Quarters > 2 > income Statement > shares Outstanding
113000000
Quarters > 2 > income Statement > income Tax Expense
59000000
Quarters > 2 > income Statement > EBITDA
488000000
Quarters > 2 > income Statement > operating Margin
13.046757164404225
Quarters > 2 > income Statement > total Other Income Expense Net
-52000000
Quarters > 2 > balance Sheet > cash
188000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1404000000
Quarters > 2 > balance Sheet > inventories
189000000
Quarters > 2 > balance Sheet > total Current Assets
2075000000
Quarters > 2 > balance Sheet > property Plant Equipment
2754000000
Quarters > 2 > balance Sheet > total Assets
15797000000
Quarters > 2 > balance Sheet > payables
1247000000
Quarters > 2 > balance Sheet > short Term Debt
174000000
Quarters > 2 > balance Sheet > long Term Debt
5858000000
Quarters > 2 > balance Sheet > total Liabilities
8754000000
Quarters > 2 > balance Sheet > equity
6929000000
Quarters > 2 > cash Flow > net Income
235000000
Quarters > 2 > cash Flow > depreciation
140000000
Quarters > 2 > cash Flow > change In Working Capital
-90000000
Quarters > 2 > cash Flow > cash From Operations
314000000
Quarters > 2 > cash Flow > capital Expenditures
117000000
Quarters > 2 > cash Flow > cash From Investing
-115000000
Quarters > 2 > cash Flow > cash From Financing
-561000000
Quarters > 2 > cash Flow > net Change In Cash
-361000000
Quarters > 2 > ratios > PE
1.9469026548672566
Quarters > 2 > ratios > PB
2.9614186751334968
Quarters > 2 > ratios > ROE
3.1750613364121807
Quarters > 2 > ratios > ROA
1.392669494207761
Quarters > 2 > ratios > FCF
197000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.07428355957767722
Quarters > 2 > health Score
51
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2621000000
Quarters > 3 > income Statement > cost Of Revenue
1763000000
Quarters > 3 > income Statement > gross Profit
858000000
Quarters > 3 > income Statement > operating Expenses
497000000
Quarters > 3 > income Statement > operating Income
361000000
Quarters > 3 > income Statement > interest Expense
72000000
Quarters > 3 > income Statement > pretax Income
304000000
Quarters > 3 > income Statement > net Income
222000000
Quarters > 3 > income Statement > eps
1.9646017699115044
Quarters > 3 > income Statement > dividends Per Share
84000000
Quarters > 3 > income Statement > shares Outstanding
113000000
Quarters > 3 > income Statement > income Tax Expense
68000000
Quarters > 3 > income Statement > EBITDA
507000000
Quarters > 3 > income Statement > operating Margin
13.773368943151468
Quarters > 3 > income Statement > total Other Income Expense Net
-57000000
Quarters > 3 > balance Sheet > cash
549000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1304000000
Quarters > 3 > balance Sheet > inventories
188000000
Quarters > 3 > balance Sheet > total Current Assets
2392000000
Quarters > 3 > balance Sheet > property Plant Equipment
2764000000
Quarters > 3 > balance Sheet > total Assets
16153000000
Quarters > 3 > balance Sheet > payables
1389000000
Quarters > 3 > balance Sheet > short Term Debt
775000000
Quarters > 3 > balance Sheet > long Term Debt
5615000000
Quarters > 3 > balance Sheet > total Liabilities
9257000000
Quarters > 3 > balance Sheet > equity
6778000000
Quarters > 3 > cash Flow > net Income
222000000
Quarters > 3 > cash Flow > depreciation
135000000
Quarters > 3 > cash Flow > change In Working Capital
13000000
Quarters > 3 > cash Flow > cash From Operations
464000000
Quarters > 3 > cash Flow > capital Expenditures
123000000
Quarters > 3 > cash Flow > cash From Investing
-502000000
Quarters > 3 > cash Flow > cash From Financing
-170000000
Quarters > 3 > cash Flow > net Change In Cash
-215000000
Quarters > 3 > ratios > PE
1.9646017699115044
Quarters > 3 > ratios > PB
3.027393036293892
Quarters > 3 > ratios > ROE
3.2753024491000295
Quarters > 3 > ratios > ROA
1.3743577044511857
Quarters > 3 > ratios > FCF
341000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.13010301411674932
Quarters > 3 > health Score
51
Valuation > metrics > PE
22.2042
Valuation > metrics > PB
2.8271796638192344
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
3.37558556076054
Profitability > metrics > ROA
10.178645616950561
Profitability > metrics > Net Margin
0.08700284090909091
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.2153485808762745
Risk > metrics > Interest Coverage
5.594202898550725
Risk > final Score
52
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.1279287722586693
Liquidity > metrics > Quick Ratio
1.0407685098406747
Liquidity > final Score
78
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
69.72606963706109
Prev Profitabilities > 0
53
Prev Profitabilities > 1
49
Prev Profitabilities > 2
47
Prev Risks > 0
55
Prev Risks > 1
49
Prev Risks > 2
50
Prev Liquidities > 0
78
Prev Liquidities > 1
87
Prev Liquidities > 2
78
Updated At
2025-12-13T00:35:08.953Z
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
0.8Next Payout:
Jan 28, 2026Yield:
1.7622 %What Quest Diagnostics (DGX)'s Octave MS Collaboration Means For Shareholders - simplywall.st
12/7/2025
What Quest Diagnostics (DGX)'s Octave MS Collaboration Means For Shareholders simplywall.st
Read more →Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward - 富途牛牛
12/6/2025
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward 富途牛牛
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$197.3125
Analyst Picks
Strong Buy
8
Buy
1
Hold
10
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 87.81% of the total shares of Quest Diagnostics Incorporated
1.
Vanguard Group Inc(12.7286%)
since
2025/06/30
2.
BlackRock Inc(9.2226%)
since
2025/06/30
3.
T. Rowe Price Associates, Inc.(6.434%)
since
2025/06/30
4.
State Street Corp(4.6368%)
since
2025/06/30
5.
JPMorgan Chase & Co(3.8737%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(3.1382%)
since
2025/07/31
7.
Boston Partners Global Investors, Inc(2.7184%)
since
2025/06/30
8.
Geode Capital Management, LLC(2.6671%)
since
2025/06/30
9.
Victory Capital Management Inc.(2.5122%)
since
2025/06/30
10.
Vanguard 500 Index Investor(2.4699%)
since
2025/07/31
11.
Vanguard Mid Cap Index Institutional(2.2271%)
since
2025/07/31
12.
Morgan Stanley - Brokerage Accounts(1.9183%)
since
2025/06/30
13.
Dimensional Fund Advisors, Inc.(1.7003%)
since
2025/06/30
14.
Victory Sycamore Established Value R(1.6991%)
since
2025/06/30
15.
Wells Fargo & Co(1.6423%)
since
2025/06/30
16.
Grantham, Mayo, Van Otterloo & Co., LLC(1.5631%)
since
2025/06/30
17.
Amvescap Plc.(1.483%)
since
2025/06/30
18.
Bank of America Corp(1.4305%)
since
2025/06/30
19.
Wellington Management Company LLP(1.4301%)
since
2025/06/30
20.
Fidelity 500 Index(1.2655%)
since
2025/07/31
21.
Davis Selected Advisers(1.2112%)
since
2025/06/30
22.
SPDR® S&P 500® ETF(1.2087%)
since
2025/08/31
23.
iShares Core S&P 500 ETF(1.2014%)
since
2025/08/31
24.
NORGES BANK(1.1855%)
since
2025/06/30
25.
JPM US Equity Income-Composite(1.156%)
since
2025/06/30
26.
JPMorgan Equity Income I(1.156%)
since
2025/07/31
27.
JHancock Disciplined Value I(1.1343%)
since
2025/07/31
28.
AllianceBernstein L.P.(1.1105%)
since
2025/06/30
29.
FMR Inc(1.1048%)
since
2025/06/30
30.
UBS Asset Mgmt Americas Inc(1.0879%)
since
2025/06/30
31.
T. Rowe Price U.S. Value Equity Tr-D(1.0347%)
since
2025/06/30
32.
JPMorgan Mid Cap Value L(1.0129%)
since
2025/07/31
33.
Vanguard Windsor Investor Shares(1.0028%)
since
2025/06/30
34.
JPM US Mid Cap Value-Composite(0.9933%)
since
2025/06/30
35.
T. Rowe Price U.S. Large-Cap Core Tr-C(0.9447%)
since
2025/06/30
36.
T. Rowe Price US Dividend Growth Eq Comp(0.93%)
since
2025/06/30
37.
T. Rowe Price Dividend Growth(0.93%)
since
2025/07/31
38.
Vanguard Value Index Inv(0.8848%)
since
2025/07/31
39.
T. Rowe Price US Large-Cap Core(0.878%)
since
2025/06/30
40.
T. Rowe Price US Large-Cap Core Eq Comp(0.878%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.